50th ASH Annual Meeting and Exposition (December 6 - 9, 2008): Aberrant Notch Signaling in Lymphoid Malignancies and Therapeutic Implications

Before you can access ASH's online program, you must agree to the following:

Abstracts submitted to the ASH Annual Meeting are considered embargoed from the time of submission.
For the research and study to be eligible for presentation at the ASH annual meeting, information contained in the abstract, as well as additional data and information to be presented about the research and/or study at the annual meeting, may not be made public before the abstract has been published/presented at the ASH annual meeting.

Last updated January 16, 2009. Please note that this site represents the latest program changes
and differs from the print version in some details.

Aberrant Notch Signaling in Lymphoid Malignancies and Therapeutic Implications

Saturday, December 6, 2008: 9:30 AM-11:00 AM

120-121-122-123-124-125 - North (Moscone Center)

Saturday, December 6, 2008: 4:00 PM-5:30 PM

120-121-122-123-124-125 - North (Moscone Center)

Notch-Dependent and -Independent Pathways in T-ALL

A. Thomas Look, MD

Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA

Challenges and Opportunities for Effective NOTCH1 Targeting in T-ALL

Adolfo A. Ferrando, MD, PhD

Institute for Cancer Genetics, Columbia University, New York, NY

Notch and Leukemia: Lessons from Mouse Models

Warren S. Pear, MD, PhD

University of Pennsylvania, Philadelphia, PA

See more of: Scientific Program

<< Previous Session | Next Session >>